Axa’s Abercrombie & Fitch ANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-67,045
| Closed | -$5.55M | – | 123 |
|
|
2025
Q2 | $5.55M | Sell |
67,045
-560
| -0.8% | -$42.5K | 0.02% | 539 |
|
|
2025
Q1 | $5.16M | Sell |
67,605
-11,745
| -15% | -$1.26M | 0.02% | 528 |
|
|
2024
Q4 | $11.9M | Buy |
79,350
+7,146
| +10% | +$1.04M | 0.04% | 356 |
|
|
2024
Q3 | $10.1M | Buy |
72,204
+55,695
| +337% | +$8.47M | 0.03% | 391 |
|
|
2024
Q2 | $2.94M | Buy |
+16,509
| New | +$2.39M | 0.01% | 671 |
|
|
2024
Q1 | – | Sell |
-26,800
| Closed | -$2.36M | – | 1064 |
|
|
2023
Q4 | $2.36M | Sell |
26,800
-1,500
| -5% | -$107K | 0.01% | 705 |
|
|
2023
Q3 | $1.6M | Sell |
28,300
-10,100
| -26% | -$448K | 0.01% | 754 |
|
|
2023
Q2 | $1.45M | Sell |
38,400
-4,400
| -10% | -$125K | ﹤0.01% | 776 |
|
|
2023
Q1 | $1.19M | Buy |
42,800
+24,900
| +139% | +$693K | ﹤0.01% | 845 |
|
|
2022
Q4 | $410K | Buy |
+17,900
| New | +$353K | ﹤0.01% | 1011 |
|
|
2022
Q2 | – | Sell |
-39,900
| Closed | -$1.28M | – | 1111 |
|
|
2022
Q1 | $1.28M | Sell |
39,900
-11,300
| -22% | -$392K | ﹤0.01% | 913 |
|
|
2021
Q4 | $1.78M | Sell |
51,200
-19,000
| -27% | -$742K | ﹤0.01% | 861 |
|
|
2021
Q3 | $2.64M | Buy |
70,200
+50,200
| +251% | +$1.94M | 0.01% | 809 |
|
|
2021
Q2 | $929K | Buy |
+20,000
| New | +$806K | ﹤0.01% | 1018 |
|
|
2019
Q3 | – | Sell |
-93,628
| Closed | -$1.5M | – | 1299 |
|
|
2019
Q2 | $1.5M | Sell |
93,628
-3,472
| -4% | -$80.3K | 0.01% | 898 |
|
|
2019
Q1 | $2.66M | Buy |
97,100
+20,100
| +26% | +$451K | 0.01% | 797 |
|
|
2018
Q4 | $1.54M | Sell |
77,000
-32,000
| -29% | -$599K | 0.01% | 875 |
|
|
2018
Q3 | $2.3M | Buy |
109,000
+33,200
| +44% | +$805K | 0.01% | 847 |
|
|
2018
Q2 | $1.86M | Buy |
75,800
+19,800
| +35% | +$518K | 0.01% | 873 |
|
|
2018
Q1 | $1.36M | Buy |
56,000
+42,200
| +306% | +$892K | 0.01% | 935 |
|
|
2017
Q4 | $241K | Buy |
+13,800
| New | +$209K | ﹤0.01% | 1281 |
|
|
2017
Q1 | – | Sell |
-17,600
| Closed | -$211K | – | 1261 |
|
|
2016
Q4 | $211K | Buy |
17,600
+4,800
| +38% | +$71.3K | ﹤0.01% | 1203 |
|
|
2016
Q3 | $203K | Hold |
12,800
| – | – | ﹤0.01% | 1165 |
|
|
2016
Q2 | $228K | Buy |
+12,800
| New | +$305K | ﹤0.01% | 1148 |
|
|
2016
Q1 | – | Sell |
-131,262
| Closed | -$3.54M | – | 1324 |
|
|
2015
Q4 | $3.54M | Buy |
+131,262
| New | +$3.05M | 0.02% | 654 |
|
|
2013
Q3 | – | Sell |
-43,600
| Closed | -$1.97M | – | 1280 |
|
|
2013
Q2 | $1.97M | Buy |
+43,600
| New | +$2.15M | 0.01% | 706 |
|
Other funds holding ANF
Axa's ANF Position: Q3 2025 in Review
Axa sold out of Abercrombie & Fitch (ANF) in Q3 2025, closing a stake of 67,045 shares — an estimated $5.55M sold.
Axa first reported a position in ANF in Q2 2013 and held it in 26 quarters. The position peaked at $11.9M in Q4 2024. 406 funds tracked by Wall St. Rank hold ANF as of Q3 2025.
- Axa reported no remaining Abercrombie & Fitch position as of Q3 2025 after selling out during the quarter.
- Axa sold 67,045 Abercrombie & Fitch shares in Q3 2025, an estimated $5.55M.
- Axa first reported a position in Abercrombie & Fitch in Q2 2013 and held it in 26 quarters.
- Axa's Abercrombie & Fitch position peaked at $11.9M in Q4 2024.
- 406 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.